title: Activity of synthetic chalcones in hamsters experimentally infected with Leishmania (Viannia) braziliensis.
abstract: The purpose of this study is to evaluate the toxicity of synthetic chalcones 1 and 2 in uninfected hamsters and anti-Leishmania activity of synthetic chalcones 1 and 2 in hamsters infected with Leishmania (Viannia) braziliensis. For the toxicity test, uninfected animals were treated with chalcones 1 and 2, and clinical and biochemical parameters and histological aspects of the liver and kidneys were assessed. Chalcones 1 and 2 were then intraperitoneally or topically administered (10 mg/kg body weight) three times per week in animals infected with promastigotes of L. (V.) braziliensis. We monitored the thickness of the infected footpads, determined parasitic load, performed histological analysis, and detected apoptosis in situ. The results were analyzed using Student's t test and Mann-Whitney test at a significance level of 5%. Neither of the chalcones showed toxicity. Chalcone 2 administered intraperitoneally significantly reduced the thickness of the infected footpad compared with the beginning of treatment. The parasite load of the lymph node and spleen was reduced in the groups treated with chalcones 1 (topical) and 2 (intraperitoneal). Chalcone 2 (topical) reduced parasite burden only in the lymph node. The histological analysis revealed reconstitution of the tissue and reductions of inflammation and apoptosis in the infected footpad in these groups. The synthetic chalcones 1 (topical) and 2 (intraperitoneal and topical) at a dose of 10 mg/kg showed anti-Leishmania activity in vivo, no renal or hepatic toxicity, and a reduction of apoptosis of the cells in the lesions. These chalcones may have substantial potential for the treatment of cutaneous leishmaniasis.
authors.affiliation: Programa de Pós-Graduação em Ciências da Saúde, Universidade Estadual de Maringá, Maringá, Brazil.
authors.forename: Tatiane F P
authors.initials: TF
authors.lastname: de Mello
authors.forename: Bruna M
authors.initials: BM
authors.lastname: Cardoso
authors.forename: Sara N
authors.initials: SN
authors.lastname: Lopes
authors.forename: Heriberto R
authors.initials: HR
authors.lastname: Bitencourt
authors.forename: Evandra M
authors.initials: EM
authors.lastname: Voltarelli
authors.forename: Luzmarina
authors.initials: L
authors.lastname: Hernandes
authors.forename: Sandra M A
authors.initials: SM
authors.lastname: Aristides
authors.forename: Maria V C
authors.initials: MV
authors.lastname: Lonardoni
authors.forename: Thais G V
authors.initials: TG
authors.lastname: Silveira
mesh_terms: D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D047188:Chalcones / Q000138:chemical synthesis / Q000627:therapeutic use*; D006224:Cricetinae; D005260:Female; D007892:Leishmania braziliensis; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D008099:Liver / Q000469:parasitology; D059208:Parasite Load; D013154:Spleen / Q000469:parasitology
chemical_list: D000981:Antiprotozoal Agents; D047188:Chalcones